399 related articles for article (PubMed ID: 31779676)
21. Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
Kuo MH; Tseng CW; Lu MC; Tung CH; Tseng KC; Huang KY; Lee CH; Lai NS
Dig Dis Sci; 2021 Nov; 66(11):4026-4034. PubMed ID: 33387124
[TBL] [Abstract][Full Text] [Related]
22. Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.
Watanabe K; Takase K; Ohno S; Ideguchi H; Nozaki A; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):470-3. PubMed ID: 21901356
[TBL] [Abstract][Full Text] [Related]
23. The difficulties of managing severe hepatitis B virus reactivation.
Roche B; Samuel D
Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
Tien YC; Yen HH; Chiu YM
Clin Exp Rheumatol; 2017; 35(5):831-836. PubMed ID: 28375829
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.
Fujita M; Sugiyama M; Sato Y; Nagashima K; Takahashi S; Mizokami M; Hata A
J Viral Hepat; 2018 Nov; 25(11):1312-1320. PubMed ID: 29770539
[TBL] [Abstract][Full Text] [Related]
27. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
28. Moderate Risk of Hepatitis B Virus Reactivation in HBsAg
Kuo MH; Tseng CW; Lee CH; Tung CH; Tseng KC; Lai NS
Sci Rep; 2020 Feb; 10(1):2456. PubMed ID: 32051458
[TBL] [Abstract][Full Text] [Related]
29. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
Vassilopoulos D; Apostolopoulou A; Hadziyannis E; Papatheodoridis GV; Manolakopoulos S; Koskinas J; Manesis EK; Archimandritis AI
Ann Rheum Dis; 2010 Jul; 69(7):1352-5. PubMed ID: 20472596
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients.
Urata Y; Uesato R; Tanaka D; Kowatari K; Nitobe T; Nakamura Y; Motomura S
Mod Rheumatol; 2011 Feb; 21(1):16-23. PubMed ID: 20668905
[TBL] [Abstract][Full Text] [Related]
32. Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.
Tsukune Y; Sasaki M; Odajima T; Isoda A; Matsumoto M; Koike M; Tamura H; Moriya K; Ito S; Asahi M; Imai Y; Tanaka J; Handa H; Koiso H; Tanosaki S; Hua J; Hagihara M; Yahata Y; Suzuki S; Watanabe S; Sugimori H; Komatsu N
Ann Hematol; 2016 Sep; 95(9):1465-72. PubMed ID: 27358178
[TBL] [Abstract][Full Text] [Related]
33. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
Yang HC; Tsou HH; Pei SN; Chang CS; Chen JH; Yao M; Lin SJ; Lin J; Yuan Q; Xia N; Liu TW; Chen PJ; Cheng AL; Hsu C;
J Hepatol; 2018 Aug; 69(2):286-292. PubMed ID: 29551710
[TBL] [Abstract][Full Text] [Related]
34. Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.
Ogawa E; Furusyo N; Murata M; Toyoda K; Hayashi T; Ura K
Liver Int; 2018 Jan; 38(1):76-83. PubMed ID: 28618152
[TBL] [Abstract][Full Text] [Related]
35. Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs.
Mori S
Mod Rheumatol; 2011 Dec; 21(6):621-7. PubMed ID: 21528424
[TBL] [Abstract][Full Text] [Related]
36. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
[TBL] [Abstract][Full Text] [Related]
37. High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia.
Chen CY; Huang SY; Cheng A; Chou WC; Yao M; Tang JL; Tsay W; Sheng WH; Tien HF
PLoS One; 2015; 10(5):e0126037. PubMed ID: 25973905
[TBL] [Abstract][Full Text] [Related]
38. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
Kusumoto S; Arcaini L; Hong X; Jin J; Kim WS; Kwong YL; Peters MG; Tanaka Y; Zelenetz AD; Kuriki H; Fingerle-Rowson G; Nielsen T; Ueda E; Piper-Lepoutre H; Sellam G; Tobinai K
Blood; 2019 Jan; 133(2):137-146. PubMed ID: 30341058
[TBL] [Abstract][Full Text] [Related]
39. Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.
Chiu YM; Lai MS; Chan KA
PLoS One; 2018; 13(4):e0196210. PubMed ID: 29694398
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
Su YC; Lin PC; Yu HC; Wu CC
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]